87 related articles for article (PubMed ID: 12847216)
1. Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells.
Steinschulte C; Taner T; Thomson AW; Bein G; Hackstein H
J Immunol; 2003 Jul; 171(2):542-6. PubMed ID: 12847216
[TBL] [Abstract][Full Text] [Related]
2. The novel cyclophilin-binding drug sanglifehrin A specifically affects antigen uptake receptor expression and endocytic capacity of human dendritic cells.
Woltman AM; Schlagwein N; van der Kooij SW; van Kooten C
J Immunol; 2004 May; 172(10):6482-9. PubMed ID: 15128841
[TBL] [Abstract][Full Text] [Related]
3. Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle.
Zhang LH; Liu JO
J Immunol; 2001 May; 166(9):5611-8. PubMed ID: 11313401
[TBL] [Abstract][Full Text] [Related]
4. The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor.
Immecke SN; Baal N; Wilhelm J; Bechtel J; Knoche A; Bein G; Hackstein H
PLoS One; 2011 Mar; 6(3):e18406. PubMed ID: 21483789
[TBL] [Abstract][Full Text] [Related]
5. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL
Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782
[TBL] [Abstract][Full Text] [Related]
6. Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action.
Zenke G; Strittmatter U; Fuchs S; Quesniaux VF; Brinkmann V; Schuler W; Zurini M; Enz A; Billich A; Sanglier JJ; Fehr T
J Immunol; 2001 Jun; 166(12):7165-71. PubMed ID: 11390463
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive activity of the immunophilin-binding drug Sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes.
Härtel C; Iblher P; Puzik A; Wortmeier K; Ebel B; Schultz C; Müller-Steinhardt M
Scand J Immunol; 2006 Jan; 63(1):26-34. PubMed ID: 16398698
[TBL] [Abstract][Full Text] [Related]
8. The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction.
Allen A; Zheng Y; Gardner L; Safford M; Horton MR; Powell JD
J Immunol; 2004 Apr; 172(8):4797-803. PubMed ID: 15067056
[TBL] [Abstract][Full Text] [Related]
9. Cyclophilin sensitivity to sanglifehrin A can be correlated to the same specific tryptophan residue as cyclosporin A.
Pemberton TJ; Kay JE
FEBS Lett; 2003 Dec; 555(2):335-40. PubMed ID: 14644438
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.
Zhang LH; Youn HD; Liu JO
J Biol Chem; 2001 Nov; 276(47):43534-40. PubMed ID: 11557753
[TBL] [Abstract][Full Text] [Related]
11. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
Clarke SJ; McStay GP; Halestrap AP
J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
[TBL] [Abstract][Full Text] [Related]
12. Sanglifehrin a blocks key dendritic cell functions in vivo and promotes long-term allograft survival together with low-dose CsA.
Hackstein H; Steinschulte C; Fiedel S; Eisele A; Rathke V; Stadlbauer T; Taner T; Thomson AW; Tillmanns H; Bein G; Hölschermann H
Am J Transplant; 2007 Apr; 7(4):789-98. PubMed ID: 17391124
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of derivatives of the novel cyclophilin-binding immunosuppressant sanglifehrin A with reduced numbers of polar functions.
Bänteli R; Wagner J; Zenke G
Bioorg Med Chem Lett; 2001 Jun; 11(12):1609-12. PubMed ID: 11412991
[TBL] [Abstract][Full Text] [Related]
14. Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data.
Sedrani R; Kallen J; Martin Cabrejas LM; Papageorgiou CD; Senia F; Rohrbach S; Wagner D; Thai B; Jutzi Eme AM; France J; Oberer L; Rihs G; Zenke G; Wagner J
J Am Chem Soc; 2003 Apr; 125(13):3849-59. PubMed ID: 12656618
[TBL] [Abstract][Full Text] [Related]
15. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells.
Hackstein H; Morelli AE; Larregina AT; Ganster RW; Papworth GD; Logar AJ; Watkins SC; Falo LD; Thomson AW
J Immunol; 2001 Jun; 166(12):7053-62. PubMed ID: 11390449
[TBL] [Abstract][Full Text] [Related]
16. Structure of human cyclophilin A in complex with the novel immunosuppressant sanglifehrin A at 1.6 A resolution.
Kallen J; Sedrani R; Zenke G; Wagner J
J Biol Chem; 2005 Jun; 280(23):21965-71. PubMed ID: 15772070
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway.
Chiang PH; Wang L; Bonham CA; Liang X; Fung JJ; Lu L; Qian S
J Immunol; 2004 Feb; 172(3):1355-63. PubMed ID: 14734710
[TBL] [Abstract][Full Text] [Related]
18. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential.
Vieira PL; Kaliński P; Wierenga EA; Kapsenberg ML; de Jong EC
J Immunol; 1998 Nov; 161(10):5245-51. PubMed ID: 9820496
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells.
Kuipers H; Hijdra D; De Vries VC; Hammad H; Prins JB; Coyle AJ; Hoogsteden HC; Lambrecht BN
J Immunol; 2003 Oct; 171(7):3645-54. PubMed ID: 14500662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
